Homologous recombination has a dual role in eukaryotic organisms. Firstly, it is responsible for the creation of genetic variability during meiosis by directing the formation of reciprocal crossovers that result in random combinations of alleles and traits. Secondly, in mitotic cells, it maintains the integrity of the genome by promoting the faithful repair of DNA double-strand breaks (DSBs). In vertebrates, it therefore plays a key role in tumour avoidance. Mutations in the tumour suppressor protein BRCA2 are associated with predisposition to breast and ovarian cancers, and loss of BRCA2 function leads to genetic instability. BRCA2 protein interacts directly with the RAD51 recombinase and regulates recombinationmediated DSB repair, accounting for the high levels of spontaneous chromosomal aberrations seen in BRCA2-defective cells. Recent observations indicate that BRCA2 also plays a critical role in meiotic recombination, this time through direct interactions with the meiosis-specific recombinase DMC1. The interactions of BRCA2 with RAD51 and DMC1 lead us to suggest that the BRCA2 tumour suppressor is a universal regulator of recombinase actions.
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The dual functions of recombination
The structural integrity of DNA is continually being challenged due to the presence of physical and chemical carcinogens in our environment. In addition to DNA lesions caused by exogenous agents, DNA suffers spontaneous decay, replication errors, and oxidative and other damages that result from normal metabolic processes (Lindahl, 1993) . The repair of damaged DNA is therefore crucial for the maintenance of genome integrity, and as a result, all organisms have evolved a wide variety of DNA repair pathways that can restore DNA structure and the information encoded within it (Hoeijmakers, 2001 ).
In yeast, it has been shown that a single un-repaired double-strand break (DSB) in DNA can lead to cell death, indicating that DSBs pose one of the most dangerous forms of DNA lesions (Bennett et al., 1993) . As a consequence, eukaryotic cells contain several DNA repair pathways that can specifically recognize DSBs and initiate the efficient repair of the DNA backbone ( Figure 1 ). There are two primary mechanisms of DSB repair in vertebrates, known as non-homologous end joining and homologous recombination (HR). Non-homologous end joining occurs by a relatively simple end-splicing mechanism, but is potentially error-prone and can lead to the loss of genetic information (Hoeijmakers, 2001) . It is primarily utilized during the G1 phase of the cell cycle. In contrast, DSB repair by HR is generally error free and functional during the S and G2 phases. The difference in cell cycle timing reflects the role that HR plays in the repair of collapsed replication forks, whereas both HR and non-homologous end joining can promote the repair of DSBs caused by ionizing radiation (IR) or genotoxic stress. HR therefore plays a critical role in the maintenance of genome integrity in replicating cells.
Two simplified mechanisms for HR are shown in Figure 1 . The process is initiated by the resection of the DSB termini to expose protruding 3 0 -single-stranded DNA (ssDNA) tails, to which the essential recombinase RAD51 will bind and form active nucleoprotein filaments ( Figure 1c ). RAD51 loading is facilitated by the ssDNA-binding protein RPA and by RAD52. The RAD51 nucleoprotein filament mediates a search for homology within the sister chromatid, which in turn serves as a template for DNA synthesis to restore any lost sequences at the break site and ultimately regenerate intact DNA (West, 2003; Sung and Klein, 2006) . The tumour suppressor and breast cancer-susceptibility gene BRCA2 is required for normal levels of HR-mediated DSB repair (Yu et al., 2000; Moynahan et al., 2001) , providing an important link between the ability of a cell to maintain genome stability and tumorigenesis.
The creation of a DSB in DNA is not always an accidental and problematic event. A large number of DSBs are deliberately created in the DNA of germ-line cells undergoing meiosis, where they serve as sites for the initiation of genetic recombination between parental chromosomes. Meiosis is a key event in the life cycle of all sexually reproducing organisms. It promotes the transition from diploid to haploid phase, and during this process it is essential that the maternal and paternal chromosomes recombine before the production of progeny (Neale and Keeney, 2006) . The basic mechanism of recombination during meiosis is remarkably similar to that which can occur in somatic cells, but a few key features mark important differences (Figure 2) . Firstly, the introduction of DSBs during meiotic recombination is a deliberate and tightly controlled process that is promoted by the SPO11 DNA endonuclease. Secondly, meiotic recombination involves the actions of two recombinases, with DMC1 supplementing the actions of RAD51. Thirdly, the search for homologous sequences by nucleoprotein filaments is directed towards homologous chromosomes rather than the sister chromatids. Finally, while mitotic recombination usually leads to the formation of non-crossover products, the processing of meiotic recombination intermediates results in at least one crossover per chromosome pair.
Cellular recombinases
In all organisms, proteins belonging to the conserved family of RecA/RAD51 recombinases mediate the DNA-DNA interactions required for mitotic and meiotic recombination. They have the unique ability to search for homologous sequences and to catalyse the exchange of DNA strands from one molecule to another. Most eukaryotes possess two recombinases: the ubiquitously expressed RAD51 (Rad51 in Saccharomyces cerevisiae, Rhp51 in S. pombe, and RAD51 in vertebrates), and its meiosis-specific homologue DMC1. RAD51 is essential in mammals, as indicated by the embryonic lethality associated with the Rad51 À/À k/o in the mouse (Lim and Hasty, 1996; Tsuzuki et al., 1996) . In contrast, Dmc1 À/À mice develop normally but are infertile due to defects in chromosome synapsis during meiotic recombination (Pittman et al., 1998; Yoshida et al., 1998) . 
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Figure 1 Schematic illustration of DNA double-strand break (DSB) repair. (a) In the S/G2 phases of the cell cycle, DSB repair is predominantly carried out by homologous recombination (HR). (b) DNA resection produces 3 0 single-stranded DNA (ssDNA) tails that serve as the initiation site for RAD51 filament formation (c). (d) Homologous pairing and strand invasion reactions take place with the sister chromatid to form a D-loop structure. Two possible mechanisms of HR can then take place involving the formation and resolution of Holliday junctions (e-g) or synthesis-dependent strand annealing (SDSA) (i-k). The products of mitotic recombination are generally non-crossovers. Non-homologous end joining can take place at all times throughout the cell cycle but is particularly useful in G1 when HR is inactive (h). MRN complex, MRE11/RAD50/NBS1 complex; NHEJ, non-homologous end joining Human RAD51 and DMC1 are relatively small proteins of 339 and 340 amino acids, respectively. They contain a large core domain that is homologous to the catalytic domain of Escherichia coli RecA protein and contains the Walker A and B motifs responsible for ATP binding and hydrolysis (Figure 3a ). This domain is very similar in DMC1 and RAD51, whereas the N-terminal regions of the two recombinases are more divergent. Recombinant RAD51 and DMC1 proteins form oligomeric ring structures of seven or eight monomers, respectively (Shin et al., 2003; Kinebuchi et al., 2004) . However, they are functionally active when associated with DNA in the form of a highly ordered right-handed helical nucleoprotein filament (Figure 3b ) (Benson et al., 1994; Conway et al., 2004; Sehorn et al., 2004) . It is within this nucleoprotein filament that DNA interactions take place between homologous sequences.
In undamaged cells, RAD51 is normally distributed throughout the nucleus, but during S phase or after treatment with DNA-damaging agents such as IR or mitomycin C, RAD51 forms distinct nuclear foci (Haaf et al., 1995; Scully et al., 1997) . These foci are thought to represent sites on chromatin where DNA repair reactions take place. Similarly, RAD51 forms foci on meiotic chromosomes, where it colocalizes with DMC1 (Barlow et al., 1997; Tarsounas et al., 1999) . These foci appear similar to the RAD51 foci observed in somatic cells after DNA damage and presumably identify sites of meiotic recombination (Haaf et al., 1995; Raderschall et al., 1999) .
It is not known why meiotic recombination requires two recombinases, while RAD51 is sufficient to mediate mitotic recombination. Indeed, the proteins appear to be so similar, certainly in terms of their molecular structure and reactions catalysed, that it has been difficult to elucidate the specific role played by DMC1 during meiotic recombination. What is so special about DMC1 that permits recombination between homologous chromosomes rather than sister chromatids? Much of our current understanding of the mechanism of meiotic recombination comes from studies carried out in yeast, partly because rad51 mutants are viable in this organism. In S. cerevisiae, the appearance of Dmc1/Rad51 foci coincides with the formation of Spo11-induced DSBs, and the foci tend to disappear as the chromosomes synapse (Shinohara et al., 2000) .
This review summarizes our current understanding of how BRCA2 contributes to the control of the recombination process, both during DSB repair in somatic cells and at meiosis. We speculate on how BRCA2 may function as a universal regulator of both RAD51 and the meiosis-specific DMC1 recombinase during recombination.
BRCA2 -a mediator of homologous recombination
Breast cancer represents one of the most common cancers and accounts for about one in three of all cancers in women. Approximately 5-10% of individuals that develop breast cancers are genetically predisposed to the disease, and of these 10-30% have been attributed 
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T Thorslund and SC West to mutations in the tumour suppressor gene BRCA2. The penetrance of having BRCA2 mutations is severethere is a 50% risk of developing cancer before the age of 50 years and an 80% risk before the age of 70 years. The BRCA2 gene was identified in 1995 (Wooster et al., 1995) , and it soon became apparent that BRCA2 is intimately involved in maintaining genomic stability via interactions with, and regulation of, the RAD51 recombinase. The direct association of mouse BRCA2 with RAD51 was first observed in 1997 by yeast twohybrid analyses, using a 100 amino-acid-long C-terminal region of BRCA2 as bait for RAD51 (Sharan et al., 1997) . The interaction between RAD51 and BRCA2 was further established by co-immunoprecipitation of endogenous BRCA2 and RAD51 (Chen et al., 1998a, b; Marmorstein et al., 1998) . RAD51 and BRCA2 were also shown to colocalize in nuclear foci in somatic cells after IR treatment (Tarsounas et al., 2004) . Interestingly, the formation of RAD51 foci after DNA damage was shown to be dependent upon functional BRCA2, a result that led to suggestions that BRCA2 is required for the recruitment of RAD51 to sites of DSBs, and thus for the cellular function of RAD51 (Sharan et al., 1997; Yuan et al., 1999) . Consistent with this view, BRCA2-deficient murine and human cells exhibit a spontaneous genome instability phenotype that involves the accumulation of chromosome breaks and radial chromosomes, presumably due to defects in the repair of replicationassociated DSBs (Patel et al., 1998; Yu et al., 2000; Moynahan et al., 2001; Tutt et al., 2001) .
Perhaps surprisingly, orthologues of the BRCA2 gene have been found in a variety of evolutionary diverse taxa (Figure 4a ), such as the smut fungus Ustilago maydis (UmBRH2) (Kojic et al., 2002) , the nematode Caenorhabditis elegans (CeBRC-2) (Martin et al., 2005) , the plant Arabidopsis thaliana (AtBRCA2) (Siaud et al., 2004) , as well as vertebrates such as chicken (cBRCA2) (Takata et al., 2002) (Figure 4a ). Human BRCA2 is a very large polypeptide of 3418 amino acids and it contains a number of recognizable motifs, some of which can be found in all BRCA2 homologues. Most characteristic are the BRC motifs and the ssDNAbinding region. In human BRCA2, the ssDNA-binding region is composed of a conserved helical domain and three OB folds. The structure of this region has been determined by X-ray crystallography and is thought to be important for the recruitment of RAD51 to DSBs (Yang et al., 2002) .
Binding and regulation of RAD51 by the BRC motifs of BRCA2
All BRCA2 proteins contain one or more BRC motif, which is a degenerate repetitive sequence approximately 70 amino acids in length, containing a core of 25 amino acids (Figures 4a and b) . Human BRCA2 has eight BRC motifs, six are present in chicken BRCA2, four in AtBRCA2, whereas only a single BRC motif appears to be present in the U. maydis and C. elegans BRCA2 homologues. The common presence of this motif indicates its critical importance, which is thought to be due to its ability to bind directly to RAD51. Interactions between RAD51 and various BRCA2 fragments containing different BRC motifs have been studied using the yeast two-hybrid system and also by pull-down analyses using tagged proteins. The first yeast twohybrid studies demonstrated the interaction of RAD51 with six of the BRC motifs, namely BRC1/BRC2/ BRC3/BRC4 and BRC7/BRC8 (Wong et al., 1997) . Using a semiquantitative yeast two-hybrid assay, it was estimated that a fragment containing BRC motifs 1-4 interacted approximately 5 Â stronger with RAD51 than a fragment containing BRC motifs 5-8 (Chen et al., 1998b) , and that the affinity of BRC4 for RAD51 was 5 Â stronger than that seen with BRC1 . Others have reported yeast two-hybrid studies with individual BRC motifs showing strong interactions between BRC motifs 1-4 and RAD51, but saw only weak evidence for interactions between RAD51 and BRC motifs 5-8 (Thorslund et al., 2007) .
When analysed in pull-downs, using glutathione S-transferase-tagged BRCA2 fusion proteins, it was shown that glutathione S-transferase-BRC1, a fragment of BRCA2 containing BRC2, and also a larger fragment containing both BRC3 and BRC4 interact with RAD51, whereas a multitude of different glutathione S-transferase-tagged fragments of BRCA2 containing BRC5-BRC8 did not interact with RAD51 (Chen et al., 1998b) . Similarly, it was shown that a glutathione S-transferasetagged fragment of BRCA2 containing BRC1-2, and a fragment containing BRC3-5 interacted with RAD51, whereas a fragment containing BRC5-8 failed to pulldown RAD51 Thorslund et al., 2007) . Hence, the ability of different BRC motifs to bind to RAD51 varies from one motif to another and detection of an interaction is dependent upon the method of analysis. The differences in affinity may reflect the degree of divergence from the critical residues of the BRC consensus sequence (Figure 4b) .
The generally conserved nature of BRC motifs indicates that they are likely to interact with a unique motif or region in RAD51. It has been demonstrated that both BRC3 and BRC4 interact with the RAD51 core domain (a region of RAD51 lacking the N-terminal domain), suggesting that some aspect of the core represents the site of interaction (Wong et al., 1997; Esashi et al., 2007) . Further insight into this interaction was provided when the structure of a protein comprising BRC4 fused to the RAD51 core was solved by X-ray crystallography. It was revealed that BRC4 interacts with RAD51 by mimicking the structural motif in RAD51 that mediates the protomer-protomer contacts necessary for oligomerization (Pellegrini et al., 2002) . Consistent with this, it has been shown that BRC4 interacts with RAD51 to form stable BRC4-RAD51 heterodimers that cannot bind DNA (Davies et al., 2001) . The structural studies also showed that the conserved F-TASGK residues (a critical part of the BRC consensus sequence) of BRC4 (Figure 4b ) are involved in mediating hydrophobic and polar interactions with RAD51. The flanking non-conserved residues, however, could be responsible for the higher affinity that Consensus F-TASGK- 
Regulation of recombination by BRCA2 T Thorslund and SC West
BRC4 shows for binding RAD51 compared to some of the other BRC motifs (Pellegrini et al., 2002) . Further insights into the interactions of the BRC motifs and RAD51 have been provided from studies carried out with small synthetic peptides. A unifying theme that comes out of these experiments is that there are differences that depend on which BRC motif is being analysed, and under what reaction conditions. Due to the availability of the BRC4-RAD51 core structure, many studies have focused on a peptide corresponding to BRC4 itself. The BRC4 peptide was found to disrupt RAD51 filaments, presumably by binding RAD51 monomers in solution, thereby shifting the equilibrium towards BRC4-RAD51 heterodimer formation (Davies and Pellegrini, 2007; Esashi et al., 2007) . However, this disruptive effect was only observed when BRC4 was present in molar excess compared to RAD51, and at lower concentrations of BRC4 it was found to associate with RAD51 filaments formed on dsDNA in the presence of the non-hydrolysable ATP analogue 5 0 -adenylyl-b, g-imidodiphosphate (AMP-PNP) (Galkin et al., 2005) . When similar experiments were carried out with BRC3, it was found that excess BRC3 could again dissociate RAD51 filaments, but only in the presence of ATP, while sub-stoichiometric amounts of BRC3 were found to form stable associations with the RAD51 filaments. In the presence of a non-hydrolysable ATP analogue, BRC3 could form stable associations with the RAD51 filaments even when in excess over RAD51 (Galkin et al., 2005) . That the different BRC motifs are non-equivalent in their ability to interact with RAD51 is further strengthened by the observation that a single mutation in RAD51-A190V prevents RAD51 interaction with BRC3 but not BRC4 .
That BRC3 and BRC4 can interact with RAD51 filaments or can adversely affect their stability may indicate a potential regulatory function for the BRC motifs. However, this 'yin and yang' concept does not appear to correlate well with the positive role that BRCA2 protein plays in RAD51-mediated recombination. To understand the molecular function of BRCA2, it will be necessary to purify the protein to homogeneity. Unfortunately, at present, this appears to be an exceedingly difficult task, due in part to the large size of the protein (384 kDa) and its propensity to degrade.
A number of in vivo studies have helped to define the contribution of the various domains of BRCA2 in relation to its biological functions. For example, it has been shown that the BRCA2-deficient pancreatic cancer cell line called CAPAN-1 is hypersensitive to methyl methanesulphonate and other DNA-damaging agents. These cells have lost one BRCA2 allele and contain a truncating (6174delT) mutation within BRC7 that leads to the production of a truncated BRCA2 protein containing just the first six BRC motifs without the ssDNA-binding domain (Goggins et al., 1996) . Despite the presence of these BRC motifs, CAPAN-1 cells fail to form RAD51 foci in response to IR (Yuan et al., 1999) , indicating the important roles played by the ssDNAbinding domain and the C-terminal region of BRCA2.
The methyl methanesulphonate sensitivity of CAPAN-1 cells can be rescued by transient expression of wild-type BRCA2 (Chen et al., 1998b) . Remarkably, BRCA2-deficient cells can also be, at least partially, rescued by artificial BRCA2 fusions containing just BRC3 or BRC4 fused to the ssDNA-binding domain of RPA (Saeki et al., 2006) . These fusions also restored the ability to form RAD51 foci after DNA damage, supporting the notion that the primary role of BRCA2 is to target RAD51 to ssDNA generated at a DSB, and that both the BRC motifs and the DNA-binding region of BRCA2 are indispensable for this RAD51-targeting activity.
Taken together, these results shed new light on what appear to be complex associations between the BRC motifs of BRCA2 with RAD51 and on how these interactions are necessary for regulation of RAD51 function. It is clear that not all BRC motifs are equal in terms of their interaction with RAD51, and the same is implied in terms of how the individual BRC motifs might contribute to RAD51 function. Indeed, the BRC motifs may have dual, maybe even multiple, non-exclusive roles in regulating RAD51 within the cell ( Figure 5 ). The binding of monomeric, and thereby inactive, RAD51 to the BRC motifs may be important for the sequestration of RAD51 at certain times during the cell cycle, particularly when there are no DSBs to be repaired. Upon DSB formation, however, the BRCs may play a critical role as BRCA2 elicits a rapid response by recruiting RAD51 to the breaks. The recombinase then needs to be released such that it forms active nucleoprotein filaments that can initiate recombinational repair. Whether the BRCs are positioned on BRCA2 in such a way that it helps to facilitate the establishment of a nucleoprotein filament remains to be determined. In this regard, it is interesting to note that a large fragment of BRCA2, containing all eight BRC motifs was recently purified and shown to stimulate RAD51-mediated strand exchange in vitro (Shivji et al., 2006) .
Stabilization of RAD51 nucleoprotein filaments by BRCA2 C-terminus is regulated by phosphorylation
In addition to its interaction with the BRC repeats, RAD51 also interacts with an unrelated C-terminal region of BRCA2 (Mizuta et al., 1997; Sharan et al., 1997) . This region has been mapped and is referred to as the TR2 region (Figure 4c) . TR2 is present within the region encoded by exon 27 and is highly conserved in vertebrate BRCA2 proteins, but is not found in the BRCA2 homologues from more diverse taxa. Deletion of exon 27 in the mouse leads to increased tumour incidence (McAllister et al., 2002; Donoho et al., 2003) .
It is thought that the C-terminal RAD51 interaction domain within BRCA2 serves a regulatory role in recombinational repair. It has been shown that serine 3291 in the TR2 region is phosphorylated by cyclindependent kinases at late G2 phase of the cell cycle, and that S3291-phosphorylated TR2 is unable to bind RAD51. These results indicate that the inability of RAD51 to bind the C-terminal region of BRCA2 provides a mechanism by which the cell can downregulate recombination as it approaches mitotic division.
Importantly, S3291 is de-phosphorylated in response to IR, thereby providing a positive mechanism for the activation of HR in response to DNA damage . Thus, the phosphorylation status of S3291 is important for modulating interactions between the BRCA2 C-terminus and RAD51, and may provide dual functions (inhibition and activation) during HR.
New light relating to the regulatory functions of TR2 was recently provided by observations showing that the interaction of TR2 with RAD51 is physically and functionally distinct from that mediated by the BRC motifs. Using synthetic peptides corresponding to the TR2 region, and mutant derivatives of RAD51 protein, it was shown that TR2 interacts specifically with multimeric RAD51 (filaments or rings) but cannot bind RAD51 monomers (Davies and Pellegrini, 2007; Esashi et al., 2007) . Furthermore, TR2 was found to stabilize RAD51 filaments from the disruptive actions of BRC4, leading to the suggestion that the C-terminal domain of BRCA2 plays a positive role in the establishment of functional RAD51 nucleoprotein filaments. These observations are important as they imply that the stabilization/destabilization of RAD51 filaments, mediated by the combined actions of the BRC and TR2 motifs of BRCA2, may be regulated by the phosphorylation status of S3291 (Figure 6 ). Non-phosphorylated TR2 can bind and stabilize an existing RAD51 filament, whereas phosphorylation of S3291 blocks RAD51 binding to the C-terminal region of BRCA2, leaving nucleoprotein filaments unprotected to the destabilizing influence of BRC motifs. The TR2 and BRC motifs in BRCA2 may thereby promote a coordinated response that is dependent upon the cell cycle and/or DSB formation.
Actions of BRCA2 in meiotic recombination
The first indications of a role for BRCA2 in meiosis came from studies of unicellular eukaryotes. Like the human protein, U. maydis BRH2 is required for mitotic recombination and the maintenance of genome stability. BRH2 is also required for the formation of viable haploid progeny from teliospores, showing that it is essential for meiosis (Kojic et al., 2002; Yang et al., 2005) .
In the nematode C. elegans, a null mutation in BRC-2 results in defects in meiotic recombination (Martin et al., 2005) . Similarly, evidence for a role in meiosis came from plants. Two conserved and almost identical BRCA2-like genes are found in A. thaliana, AtBRCA2(IV) and AtBRCA2(V) (roman numerals refer to the chromosome on which the gene is found). Both genes are expressed and encode AtBRCA2 homologues of 1151 amino acids (IV) and 1155 amino acids (V), respectively. The AtBRCA2 homologues contain four BRC motifs, and Phosphorylation of Ser3291 Figure 6 Stabilization of RAD51 filaments by the C-terminal region of BRCA2. During the S and early G2 phases of the cell cycle, or after DNA damage, the C-terminal TR2 region of BRCA2 is non-phosphorylated at serine 3291 and thus capable of interaction with RAD51. Interaction of TR2 with RAD51 filaments leads to their stabilization, and as a consequence HR is active in the repair of DSBs resulting from replication fork collapse or genotoxic stress. As cells approach mitosis, serine 3291 is phosphorylated, serving to downregulate HR, as TR2 cannot interact with and stabilize RAD51 filaments. HR, homologous recombination.
RAD51 binding by BRCA2
Recruitment of RAD51 to resected DSBs Stimulation of filament assembly Stimulation of filament disassembly BRC-mediated RAD51 regulation Figure 5 Putative functions of the BRCA2 BRC motifs in RAD51 regulation. Binding of monomeric RAD51 to the BRC motifs of BRCA2 could inactivate and sequester RAD51 at specific stages of the cell cycle in the absence of DNA damage. Upon DNA damage, the BRCA2-RAD51 complex can relocalize to the sites of damage. The ssDNA-binding domain of BRCA2 is important for this recruitment, as are BRC-RAD51 interactions. Once at the resected DSB, the structural and topological organization of monomeric RAD51 bound to the BRC motifs may help to facilitate the initiation of RAD51 filament formation. After successful strand invasion, the ability of BRC motifs to bind monomeric RAD51 and destabilize RAD51 filaments may be important for filament disassembly. DSB, double-strand break.
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T Thorslund and SC West BRC2 is the only one that differs between the two plant BRCA2 proteins, which overall share 95% identity (Figure 4b ). Using a BRCA2 RNAi construct, which inactivates both AtBRCA2(IV) and AtBRCA2(V), expressed under the control of a meiosis-specific promoter, it was shown that BRCA2 inactivation results in partial sterility. This phenotype was dependent on SPO11, as the BRCA2 knockdown had no effect in a SPO11-deficient background (Siaud et al., 2004) , indicating that BRCA2 is required for the processing of SPO11-generated DSBs in meiotic recombination. The role of BRCA2 in meiosis in mammals has been more difficult to study due to the embryonic lethality associated with inactivating BRCA2 mutations (Ludwig et al., 1997; Sharan et al., 1997; Suzuki et al., 1997) . However, indications of its involvement in meiosis were provided by observations showing that BRCA2 is highly expressed during spermatogenesis in mice (Connor et al., 1997) and localizes to meiotic chromosomes during early meiotic prophase I when homologous chromosomes undergo synapsis (Chen et al., 1998a) . Viable mice that exhibit partial loss of function truncations in BRCA2 exon 11 displayed a complete failure in spermatogenesis (Connor et al., 1997) , whereas no meiotic defects were observed in mice where the C-terminal region, including TR2, was deleted (McAllister et al., 2002; Atanassov et al., 2005) . Conclusive evidence for the involvement of BRCA2 in meiosis was confirmed when it was shown that BRCA2 k/o mice, rescued by a bacterial artificial chromosome expressing human BRCA2, which exhibit low expression of the BRCA2 transgene in the gonads, were infertile as their spermatocytes failed to progress beyond early prophase I. In these mice, SPO11-induced DSBs occur normally, but persist without being repaired (Sharan et al., 2004) . Importantly, in these mice, both RAD51 and DMC1 failed to localize to foci on meiotic chromosomes, indicating that BRCA2 is required for localization of both recombinases to SPO11-induced DSBs.
Interactions between BRCA2 and DMC1
Two-hybrid analyses, together with pull-down studies with tagged protein constructs, showed that the AtBRCA2 proteins interact directly with both RAD51 and DMC1 (Siaud et al., 2004) . These interactions occur through the N-terminal BRC motif-containing region of BRCA2 (AtBRCA2(IV) 1-784 ). Interestingly, interactions with RAD51 were blocked by the presence of a polypeptide corresponding to the human BRC3 motif, while this peptide had no effect on AtBRCA2(IV)-AtDMC1 interactions (Dray et al., 2006) . Furthermore, the BRC2 motif of AtBRCA2(IV) was found to interact with AtDMC1, whereas the binding to RAD51 was mediated through the BRC4 motif, indicating that the AtBRC motifs exhibit different specificities for the two recombinases (Dray et al., 2006) . Details of the interactions that take place between human BRCA2 and DMC1 protein were recently described (Thorslund et al., 2007) . Using a combination of yeast two-hybrid analysis, pull-downs with recombinant tagged fusion proteins, and peptide-arrays, the primary DMC1 interaction site on BRCA2 was mapped to a motif located at BRCA2 . This novel DMC1 interaction motif has been named the PhePP motif, due to the critical importance of amino acids Phe2406, Pro2408, and Pro2409 (Figure 4d ). The PhePP motif is unrelated to the BRC repeats and located away from the RAD51 interaction sites on BRCA2. It promotes specific interactions between BRCA2 and DMC1, but not RAD51.
The PhePP motif is highly conserved in BRCA2 from a variety of vertebrate species, but has diverged in A. thaliana, U. maydis, and C. elegans (Figure 4d ). The identification of this novel DMC1-interacting motif in BRCA2 was surprising as, based on the observed interactions between AtBRCA2 and AtDMC1, it was expected that interactions between hBRCA2 and hDMC1 would be mediated though one or more of the BRC motifs. Yeast two-hybrid analyses did reveal an association between DMC1 and the BRC4 motif of hBRCA2, but this was so weak that it could not be substantiated in pull-down experiments (Thorslund et al., 2007) . Moreover, interactions could not be observed between hDMC1 and a larger fragment of BRCA2 containing all eight BRC motifs. The interactions of hBRCA2 with hDMC1, mediated through the PhePP motif, therefore contrast with those that take place with hRAD51.
hDMC1 was also found to associate with the TR2 region of BRCA2, but this interaction was weak in comparison to that which takes place between TR2 and RAD51, and was not affected by phosphorylation of S3291 (Thorslund et al., 2007) . The biological significance of this interaction may be minor as transgenic mice with C-terminal BRCA2 deletions fail to exhibit meiotic defects (McAllister et al., 2002; Atanassov et al., 2005) . This is important because it indicates that the TR2 region, which is required for the stabilization of RAD51 filaments during HR in somatic cells, is dispensable for HR during meiosis. Whether there are other factors that stabilize RAD51 filaments during meiosis, or whether at meiosis the bias is switched from RAD51 stabilization to DMC1 filament stabilization, remains to be investigated.
Although the DMC1-interacting PhePP motif identified in hBRCA2 is divergent in non-vertebrate eukaryotic species, some of the highly conserved amino acids found in mammals that are important for DMC1 interaction (for example, Phe2406 and Pro2409 of hBRCA2) are also present in AtBRCA2, UmBRH2, and CeBRC-2 (Figure 4d ). It is possible that this divergent putative PhePP motif in AtBRCA2 may, in addition to the AtBRCA2(IV)-BRC2 motif, be involved in interactions with AtDMC1, but this remains to be investigated. Interestingly, the diverged PhePP motif in C. elegans was recently shown to interact with CeRAD51 (Petalcorin et al., 2007) . C. elegans is unusual in that it lacks DMC1, and promotes meiotic recombination through the high-level expression of CeRAD51 alone (Takanami et al., 2000) . That this region of BRCA2 in humans interacts specifically with DMC1, whereas in C. elegans it interacts with RAD51, the only recombinase in this organism, may suggest a general regulatory role. Evidence for this proposal was recently obtained when it was shown that a peptide corresponding to CeBRC-2 60-89 , containing the PhePP-like motif, binds and stabilizes CeRAD51 nucleoprotein filaments (Petalcorin et al., 2007) .
Conclusions and perspectives
One priority for the future will be to understand how BRCA2 coordinates the binding of RAD51 and DMC1, and regulates their function during meiotic recombination. Given that RAD51 and DMC1 have distinct and non-overlapping binding sites on BRCA2, it is assumed that a BRCA2-RAD51-DMC1 complex may exist in vivo. Data to support this concept, however, is yet to be obtained. We suggest that the simultaneous binding of both RAD51 and DMC1 is likely to be necessary for the localization of both recombinases to meiotic chromosomes following SPO11-induced DSB formation during meiotic recombination. But how the recombinases are loaded, whether it occurs sequentially or via the formation of mixed nucleoprotein filaments remains to be determined. Little is presently known about the regions in DMC1 that mediate interactions with the PhePP domain of BRCA2, and this information may be valuable in understanding how BRCA2 regulates the coordinated actions of DMC1 and RAD51 during HR at meiosis.
Perhaps the greatest challenge will be to develop the present studies, carried out with BRCA2 peptides and fragments, in terms of understanding how this large protein functions as a whole, and towards this goal it will be a remarkable achievement to purify the full-size protein. As techniques improve, we hope that it will be possible to prepare recombinant BRCA2 for biochemical studies. The availability of full-length BRCA2 will allow the analysis of BRC-and TR2-mediated RAD51 complex formation and permit us to develop in vitro assays for BRCA2-mediated nucleoprotein filament formation. No doubt we will get answers that explain how the BRC motifs can both bind and disrupt RAD51 nucleoprotein filaments, and it is entirely possible that these apparently antagonistic effects will not be apparent with the full-size protein.
The identification of a novel DMC1 interaction site in BRCA2 suggests that mutations in BRCA2 may not only be associated with breast cancer susceptibility, but may also be associated with fertility problems. We suggest that these two phenotypes are not necessarily linked, and that specific mutations in the PhePP motif will affect interactions with DMC1 but not RAD51. The consequences will relate to defects in meiotic recombination without necessarily causing the genomic instabilities that lead to tumour predisposition.
